Sandu Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue17.1215.3017.6616.7017.46
Expenses16.4214.9417.4415.9217.08
EBITDA0.850.520.350.910.54
EBIT0.720.400.230.770.40
Profit Before Tax0.700.370.210.760.38
Net Profit0.480.270.110.550.21
Financial Ratios
Operating Profit Margin4.97%3.47%2.04%5.48%3.10%
Net Profit Margin2.81%1.77%0.62%3.31%1.20%
Earning Per Share (Diluted)0.510.260.110.570.21
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ